Skip to main content
BKYI
NASDAQ Technology

BIO-Key International 预计每股亏损7美分，收入预计激增50%

feedReported by Reuters
Sentiment info
Neutral
Importance info
7
Price
$0.591
Mkt Cap
$6.408M
52W Low
$0.509
52W High
$1.97
Market data snapshot near publication time

summarizeSummary

分析师预计BIO-Key International 将在2025年12月31日结束的季度中报告每股亏损7美分，当该公司在3月31日发布结果时。尽管预计亏损，但该公司也预计显示季度收入显著增加50.5%，达到220万美元。这份收益预览为一家微型上市公司提供了关键预期，为即将发布的报告奠定了基础。交易者将密切关注实际结果与这些估计之间的差异，权衡持续亏损与强劲的营业额增长之间的关系。2025年第四季度实际收益发布将是下一个主要催化剂。

在该公告发布时，BKYI的交易价格为$0.59，交易所为NASDAQ，所属行业为Technology，市值约为$640.8万。 52周交易区间为$0.51至$1.97。 这则新闻被评估为中性市场情绪，重要性评分为7/10。 来源：Reuters。

show_chartPrice Chart

Share this article

Copied!

feed BKYI - Latest Insights

BKYI
Apr 29, 2026, 4:46 PM EDT
Filing Type: 8-K
Importance Score:
8
BIO-key International Finalizes 1-for-10 Reverse Stock Split to Regain Nasdaq Compliance
Sentiment: Negative
View Wiseek Article
BKYI
Apr 24, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Stockholders Approve Reverse Stock Split to Address Nasdaq Compliance
Sentiment: Neutral
View Wiseek Article
BKYI
Apr 22, 2026, 4:45 PM EDT
Source: GlobeNewswire
Importance Score:
8
BIO-key Receives Nasdaq Non-Compliance Notice for Delayed 10-K Filing
Sentiment: Negative
View Wiseek Article
BKYI
Apr 20, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
BIO-key Projects 50% H1 Revenue Growth and Profitability Turnaround
Sentiment: Positive
View Wiseek Article
BKYI
Apr 16, 2026, 8:10 AM EDT
Source: Reuters
Importance Score:
8
BIO-key Forecasts 50% H1 Revenue Surge, Projects Positive Net Income
Sentiment: Positive
View Wiseek Article
BKYI
Mar 31, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
8
BIO-key Reports Strong Cash Position and Positive 2026 Outlook Despite Q4 EPS Miss
Sentiment: Neutral
View Wiseek Article
BKYI
Mar 31, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
BIO-key Reports Q4 Loss of 19 Cents Per Share, Significantly Missing Estimates
Sentiment: Negative
View Wiseek Article
BKYI
Mar 27, 2026, 9:51 AM EDT
Source: Reuters
Importance Score:
7
BIO-Key International Forecasts 7-Cent Loss Per Share, Revenue Expected to Surge 50%
Sentiment: Neutral
View Wiseek Article
BKYI
Mar 16, 2026, 4:45 PM EDT
Filing Type: DEF 14A
Importance Score:
7
BIO-key Files Definitive Proxy for Reverse Stock Split to Maintain Nasdaq Listing
Sentiment: Negative
View Wiseek Article
BKYI
Mar 06, 2026, 5:00 PM EST
Filing Type: PRE 14A
Importance Score:
8
BIO-key Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing
Sentiment: Negative
View Wiseek Article